USA

Ozempic prescriptions for some members – Orange County Register

By Nicole Goodkind | CNN

Costco now offers its U.S. members access to prescriptions for GLP-1 weight loss medications through its low-cost healthcare partner Sesame.

The warehouse retailer first partnered with Sesame, a direct-to-consumer healthcare marketplace, last fall when it began offering its members online health checks for as well just $29.

Also see: Wegovy agrees to reduce risk of heart attack and stroke in overweight patients

About two months after that announcement, Costco and Sesame noticed that customers were asking for help losing weight and began working on a new program to address that interest, said David Goldhill, co-founder and CEO of Sesame.

“The number one search term for Costco members looking for primary care on Sesame was weight loss,” Goldhill said in an interview with USA Today.

Costco and Sesame did not immediately respond to CNN’s requests for comment.

Related: Ozempic mania’s billions of bills are coming for American taxpayers

The fruit of their labor, a three-month renewable program, officially launched Tuesday and includes a video consultation with a doctor or weight loss specialist, a GLP-1 or weight loss prescription, if applicable, and a Ongoing support through unlimited messages and advice. with a health care provider.

Sesame says it has a supply of injectable semaglutide, including Ozempic and Wegovy, as well as oral weight loss medications.

The company says patients could lose 5% of their weight in just three months, 10% in six months and 15% in a year.

Learn more about Ozempic: How to pay for promising weight loss drugs

The cost of medication is not included in the $179 three-month plan, and Sesame warned on its website that without insurance, GLP-1s can cost between $950 and $1,600 per month.

Ozempic, Wegovy and other GLP-1 prescription drugs have already swept through the nation’s wealthiest demographics.

U.S. healthcare providers wrote more than nine million prescriptions for Wegovy and other injectable medications used for weight loss in the last three months of 2022 alone. JPMorgan researchers estimate that 30 million people could be taking GLP-1 drugs by 2030, or about 9% of the U.S. population.

WeightWatchers has launched a new membership plan that gives members access to doctors who can prescribe these medications. It also struck a deal worth more than $100 million to buy Sequence, a telehealth company that can offer patients virtual prescriptions, where appropriate, for these weight-loss drugs.

Luxury gyms such as Life Time are also acquiring weight-loss clinics with doctors who can prescribe GLP-1, while Equinox designs exercise programs specifically for people taking the drugs.

California Daily Newspapers

Back to top button